That is a fair point, and I do think the drug industry should be rewarded for making a product that saves lives. If we were making the comparison to the softwa

That is a fair point, and I do think the drug industry should be rewarded for making a product that saves lives. If we were making the comparison to the software industry again we wouldn't make that same comparison, we would just have the people close up shop and start another startup when their product fails and they fail to pivot. I guess the analogy just starts falling apart there.